ArticleThe Review of economic studies2019
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules.
Article in The Review of economic studies, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- Modeling the impacts of budget reductions at the U.S. NIH on research and innovation.npj health systems · 2026Article
- The rise of large language models and the direction and impact of US federal research funding.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- An evaluation of the US public-private Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) initiative.Health affairs scholar · 2026Article
- Recognizing NIH's Role in Turning Discoveries into Cancer Treatments.LES nouvelles. Licensing Executives Society (U.S.A.) · 2026Article
- Balancing innovation and integrity: the biomedical research ecosystem at a crossroads.Nature biotechnology · 2026Article
- Video game engines as the new "virtual" Skinner box.Journal of the experimental analysis of behavior · 2026Article
- Global distribution of research efforts, disease burden, and impact of US public funding withdrawal.Nature medicine · 2025Article
- Assessing the scientific and economic impacts of the experiments conducted onboard the International Space Station.NPJ microgravity · 2025Article
- Medical research and health care finance: Evidence from Academic Medical Centers.Research policy · 2025Article
- Article
- Article
- Strategic policy options to improve quality and productivity of biomedical research.Politics and the life sciences : the journal of the Association for Politics and the Life Sciences · 2025Article
- Teamwork Coaching in the Research Development Process.Small group research · 2024Article
- Quantifying public and private investment in European biopharmaceutical research and development.Health affairs scholar · 2024Article
- The NBER Orange Book Dataset: A user's guide.Research policy · 2023Article
- Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry.JAMA health forum · 2023Article
- Data, measurement and empirical methods in the science of science.Nature human behaviour · 2023Review
- What Can Economics Say about Alzheimer's Disease?Journal of economic literature · 2023Article
- Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019.JAMA health forum · 2023Article
- Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
We quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to develop a method for flexibly linking specific grant expenditures to private-sector innovations. Second, we take advantage of idiosyncratic rigidities in the rules governing NIH peer review to generate exogenous variation in funding across research areas. Our results show that NIH funding spurs the development of private-sector patents: a $10 million boost in NIH funding leads to a net increase of 2.3 patents. Though valuing patents is difficult, we report a range of estimates for the private value of these patents using different approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.